Overall 50 constituents in the samples were identified, that included 44 known components and 6 unknown components represented in the additional data files (Additional file 4: Table S1 of additional data file).
Certain regulators of proliferation and survival of newborn cells have been identified, that include growth factors and morphogens, hormones, certain neurotransmitters, intracellular signaling molecules and transcription factors [1].
Six major classes of drugs were identified that included inhibitors of glycogen synthase kinase 3 (GSK3), Raf/MEK protein kinase, PI3-kinase/AKT protein kinase, Hedgehog pathway, histone deacetylases (HDACs), and also included DNA damaging agents (Chen et al, 2014).
Several mechanisms of azole resistance have been identified, that include increased P-450-dependent ergosterol and an energy-dependent efflux pump of fluconazole, possibly via a multidrug resistance-type transporter [ 13, 14].
An ORF with 77.7% nucleotide sequence identity to the rps14 gene was identified that includes a 5' extension of 162 bp.
A minimal deleted region has been identified that includes the deleted in leukemia 2 gene (DLEU2) [ 31], which encodes a long noncoding RNA (1.0 1.8 kb) that is polyadenylated and spliced [ 31], and the miR-15a/16 miR-15a/16at is loclusternthatis to Dlocated30, 32].
Various cellulolytic enzyme paradigms have been identified that include the free enzyme systems, the cellulosome, multifunctional enzymes, and cell wall-associated enzymes.
Multiple levels of allosteric modulation are identified that include sites distributed in the extracellular ligand binding domain (e.g. Ca2+ or benzodiazepines), the transmembrane domain (e.g. general anesthetic and various allosteric modulators) and the cytoplasmic domain, as potential targets for drug design.
Several genes co-targeted by NR2E3 and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, Rarres2, Pde8a, and Nupr1.
Eight studies were identified that included decompressive surgery [ 10, 23, 29- 34].
